Baseline circulating tumor plasma cells are associated with progression-free survival in newly diagnosed multiple myeloma: a single-center real-world NGF study.

Sýkora J, Kľoc D, Dubiková B, Kurhajec S, Guman T, Sarissky M

Open source

DOI
10.4149/neo_2026_260427n133
Published
2026 Jul 22
Container
Neoplasma
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4149/neo_2026_260427n133,
  title = {Baseline circulating tumor plasma cells are associated with progression-free survival in newly diagnosed multiple myeloma: a single-center real-world NGF study.},
  author = {Sýkora J and Kľoc D and Dubiková B and Kurhajec S and Guman T and Sarissky M},
  year = {2026},
  journal = {Neoplasma},
  doi = {10.4149/neo_2026_260427n133},
  url = {https://doi.org/10.4149/neo_2026_260427n133}
}

RIS

TY  - JOUR
TI  - Baseline circulating tumor plasma cells are associated with progression-free survival in newly diagnosed multiple myeloma: a single-center real-world NGF study.
AU  - Sýkora J
AU  - Kľoc D
AU  - Dubiková B
AU  - Kurhajec S
AU  - Guman T
AU  - Sarissky M
PY  - 2026
JO  - Neoplasma
DO  - 10.4149/neo_2026_260427n133
UR  - https://doi.org/10.4149/neo_2026_260427n133
ER  - 

APA

J, S., D, K., B, D., S, K., T, G., & M, S. (2026). Baseline circulating tumor plasma cells are associated with progression-free survival in newly diagnosed multiple myeloma: a single-center real-world NGF study.. Neoplasma. https://doi.org/10.4149/neo_2026_260427n133

Source records